Clinical Trial of Human Botulism Immune Globulin

  • Stephen S. Arnon


A major theme of this conference is that botulinum toxin, nature’s most poisonous poison,1 has now been “tamed” and has acquired the distinction of becoming, through the work of Scott2 and Schantz,3 the first bacterial toxin to serve as a medicine for the betterment of humanity. So in this historic and felicitous context, it appears to be my unwelcome responsibility to remind this conference that botulinum toxin remains very much an adversary for certain select groups of patients, most notably, infants.4


Botulinum Toxin California Department Botulinum Toxin Type Clostridium Botulinum Wound Botulism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lammana C. The most poisonous poison. Science 1959; 130: 763–772.CrossRefGoogle Scholar
  2. 2.
    Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044–1049.PubMedGoogle Scholar
  3. 3.
    Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80–99.PubMedGoogle Scholar
  4. 4.
    Amon SS. Infant botulism. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, third edition. Philadelphia: WB Saunders, 1992:1095–1102 (ch. 107).Google Scholar
  5. 5.
    Amon SS, Midura TF, Clay SA, Wood RM, Chin J. Infant botulism: epidemiological, clinical, and laboratory aspects. JAMA 1977; 237: 1946–1951.CrossRefGoogle Scholar
  6. 6.
    Wilcke BW Jr, Midura TF, Amon SS. Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis 1980; 141: 419–423.PubMedCrossRefGoogle Scholar
  7. 7.
    Mills DC, Amon SS. The large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis 1987; 156: 997–998.PubMedCrossRefGoogle Scholar
  8. 8.
    Centers for Disease Control. Summary of notifiable diseases, United States, 1990. Morbid Mortal Wkly Rept 1991; 39 (53): 56.Google Scholar
  9. 9.
    Chia JK, Clark JB, Ryan CA, Pollack M. Botulism in an adult associated with foodbome intestinal infection with Clostridium botulinum. N Engl J Med 1986; 315: 239–241.PubMedCrossRefGoogle Scholar
  10. 10.
    Freedman M, Armstrong RM, Killian JM, Boland D. Botulism in a patient with jejunoileal bypass. Ann Neurol 1986; 20: 641–643.PubMedCrossRefGoogle Scholar
  11. 11.
    Sonnabend WF, Sonnabend OA, Grundler P, Ketz E. Intestinal toxicoinfection by Clostridium botulinum type Fin an adult. Lancet 1987; 1: 357–362.PubMedCrossRefGoogle Scholar
  12. 12.
    McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol 1988; 26: 1052–1054.PubMedGoogle Scholar
  13. 13.
    McCroskey LM, Hatheway CL, Woodruff BA, Greenberg JA, Jurgenson P. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J Clin Microbiol 1991; 29: 2618–2620.PubMedGoogle Scholar
  14. 14.
    Pickett J, Berg B, Chaplin E, Brunstetter-Shafer M. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 1976; 295: 770–772.PubMedCrossRefGoogle Scholar
  15. 15.
    Midura TF, Amon SS. Infant botulism: identification of Clostridium botulinum and its toxins in faeces. Lancet 1976; 2: 934–936.PubMedCrossRefGoogle Scholar
  16. 16.
    Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 1980; 69: 567–569.PubMedCrossRefGoogle Scholar
  17. 17.
    Lewis GE Jr, Metzger JF. Botulism immune plasma (human). Lancet 1978; 312: 634–635.CrossRefGoogle Scholar
  18. 18.
    Lewis GE Jr, Metzger JF. Studies on the prophylaxis and treatment of botulism. In: Eaker D, Wadstrom T, eds. Textbook of Natural Toxins. New York: Pergamon Press, 1980: 601–606Google Scholar
  19. 19.
    Ember L. Chemical weapons: plan proposed to destroy Iraqi arms. Chem Eng News 1991; 69: 6.Google Scholar
  20. 20.
    Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodbome botulism. Am J Med 1984; 76: 794–798.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Stephen S. Arnon
    • 1
  1. 1.California Department of Health ServicesBerkeleyUSA

Personalised recommendations